mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines

mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines

The advent of the Omicron variant globally has hastened the requirement for a booster vaccination dose to confer continuous protection against symptomatic SARS-CoV2 infection. However, different vaccines are available in different countries, and individuals who had adverse reactions to certain vacci...

Full description

Bibliographic Details
Main Authors: Duan, K. (Author), Huang, Y. (Author), Huo, J. (Author), Lam, K.P (Author), Li, Y. (Author), Teo, S.Y (Author), Toh, L.K (Author), Xu, S. (Author), Zhang, B. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
antibodies
B cells
booster
COVID-19
omicron
SARS-CoV-2
vaccines
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items